Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02207855

Enrollment

Registered

2014-08-04

Start date

2014-06-30

Completion date

2015-03-31

Last updated

2016-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Interventions

DRUGChloroprocaine

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 2 Years

Healthy volunteers

Inclusion criteria

* Neonates and infants who have received chloroprocaine for epidural anesthesia.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Pain score	Every 6 hours for 72 hours

Secondary

Measure	Time frame
Pain medicine consumption	Every 6 hours for 72 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026